The importance of being parasiticidal… an update on drug development for the treatment of alveolar echinococcosis

Abulaihaiti, 2015, Efficacy of albendazole-chitosan microsphere-based treatment for alveolar echinococcosis in mice, PLoS Negl. Trop. Dis., 9, 10.1371/journal.pntd.0003950 Agudelo Higuita, 2016, Cystic echinococcosis, J. Clin. Microbiol., 54, 518, 10.1128/JCM.02420-15 Albani Clara, 2014, Efficacy of albendazole in combination with thymol against Echinococcus multilocularis protoscoleces and metacestodes, Acta Trop., 140, 61, 10.1016/j.actatropica.2014.08.007 Albani, 2015, In vivo activity of albendazole in combination with thymol against Echinococcus multilocularis, Vet. Parasitol., 212, 193, 10.1016/j.vetpar.2015.06.030 Ali-Khan, 1983, Cystolytic events and the possible role of germinal cells in metastasis in chronic alveolar hydatidosis, Ann. Trop. Med. Parasitol., 77, 497, 10.1080/00034983.1983.11811742 Ammann, 1994, Effect of chemotherapy on the larval mass and the long-term course of alveolar echinococcosis, Swiss Echinococcosis Study Group. Hepatol. Baltim. Md, 19, 735 Bacciarini, 2004, Hepatic alveolar echinococcosis in cynomolgus monkeys (Macaca fascicularis), Vet. Pathol., 41, 229, 10.1354/vp.41-3-229 Barrowman, 1984, The fumarate reductase system as a site of anthelmintic attack in Ascaris suum, Biosci. Rep., 4, 879, 10.1007/BF01138170 Barth, 2012, Sensitive and specific immunohistochemical diagnosis of human alveolar echinococcosis with the monoclonal antibody Em2G11, PLoS Negl. Trop. Dis., 6, 10.1371/journal.pntd.0001877 Basto, 2017, Characterization of the activities of dinuclear thiolato-bridged arene ruthenium complexes against Toxoplasma gondii, Antimicrob. Agents Chemother., 61, 10.1128/AAC.01031-17 Bebezov, 2018, Intense focus of alveolar echinococcosis, South Kyrgyzstan, Emerg. Infect. Dis., 24, 1119, 10.3201/eid2406.161641 Beckmann, 2014, Serum albumin and α-1 acid glycoprotein impede the killing of Schistosoma mansoni by the tyrosine kinase inhibitor Imatinib, Int. J. Parasitol. Drugs Drug Resist., 4, 287, 10.1016/j.ijpddr.2014.07.005 Bellei, 2012, Inhibition of melanogenesis by the pyridinyl imidazole class of compounds: possible involvement of the Wnt/β-catenin signaling pathway, PLoS One, 7, 10.1371/journal.pone.0033021 Boubaker, 2015, Prevention and immunotherapy of secondary murine alveolar echinococcosis employing recombinant EmP29 antigen, PLoS Negl. Trop. Dis., 9, 10.1371/journal.pntd.0003795 Brack, 1997, Alveolar hydatidosis (Echinococcus multilocularis) in a captive rhesus monkey (Macaca mulatta) in Germany, Tropical Med. Int. Health, 2, 754, 10.1046/j.1365-3156.1997.d01-381.x Brehm, 2010, Echinococcus multilocularis as an experimental model in stem cell research and molecular host-parasite interaction, Parasitology, 137, 537, 10.1017/S0031182009991727 Brehm, 2010, The role of evolutionarily conserved signalling systems in Echinococcus multilocularis development and host-parasite interaction, Med. Microbiol. Immunol., 199, 247, 10.1007/s00430-010-0154-1 Brehm, 2014, On the importance of targeting parasite stem cells in anti-echinococcosis drug development, Parasite Paris Fr., 21, 72, 10.1051/parasite/2014070 Brehm, 2017, Echinococcus-host interactions at cellular and molecular levels, Adv. Parasitol., 95, 147, 10.1016/bs.apar.2016.09.001 Brunet, 2015, Description of vertebral and liver alveolar echinococcosis cases in Cynomolgus monkeys (Macaca fascicularis), BMC Vet. Res., 11, 10.1186/s12917-015-0520-8 Brunetti, 2010, Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans, Acta Trop., 114, 1, 10.1016/j.actatropica.2009.11.001 Cirilli, 2017, The sodium salt of the enantiomers of ricobendazole: preparation, solubility and chiroptical properties, J. Pharm. Biomed. Anal., 139, 1, 10.1016/j.jpba.2017.01.057 Corrêa, 2016, Ruthenium(II) complexes of 1,3-thiazolidine-2-thione: cytotoxicity against tumor cells and anti-Trypanosoma cruzi activity enhanced upon combination with benznidazole, J. Inorg. Biochem., 156, 153, 10.1016/j.jinorgbio.2015.12.024 Cumino, 2012, Echinococcus granulosus tegumental enzymes as in vitro markers of pharmacological damage: a biochemical and molecular approach, Parasitol. Int., 61, 579, 10.1016/j.parint.2012.05.007 Deplazes, 2001, Veterinary aspects of alveolar echinococcosis--a zoonosis of public health significance, Vet. Parasitol., 98, 65, 10.1016/S0304-4017(01)00424-1 Deplazes, 2017, Global distribution of alveolar and cystic echinococcosis, Adv. Parasitol., 95, 315, 10.1016/bs.apar.2016.11.001 Frey, 2017, Dogs as victims of their own worms: serodiagnosis of canine alveolar echinococcosis, Parasit. Vectors, 10, 10.1186/s13071-017-2369-0 Gelmedin, 2008, Characterization and inhibition of a p38-like mitogen-activated protein kinase (MAPK) from Echinococcus multilocularis: antiparasitic activities of p38 MAPK inhibitors, Biochem. Pharmacol., 76, 1068, 10.1016/j.bcp.2008.08.020 Gelmedin, 2010, Molecular characterisation of MEK1/2- and MKK3/6-like mitogen-activated protein kinase kinases (MAPKK) from the fox tapeworm Echinococcus multilocularis, Int. J. Parasitol., 40, 555, 10.1016/j.ijpara.2009.10.009 Gorgas, 2017, To see or not to see: non-invasive imaging for improved readout of drug treatment trials in the murine model of secondary alveolar echinococcosis, Parasitology, 144, 937, 10.1017/S0031182017000051 Gottstein, 2015, Threat of alveolar echinococcosis to public health - a challenge for Europe, Trends Parasitol., 10.1016/j.pt.2015.06.001 Grüner, 2017, Comprehensive diagnosis and treatment of alveolar echinococcosis: a single-center, long-term observational study of 312 patients in Germany, GMS Infect. Dis., 1 Hemer, 2012, In vitro efficacy of the anticancer drug imatinib on Echinococcus multilocularis larvae, Int. J. Antimicrob. Agents, 40, 458, 10.1016/j.ijantimicag.2012.07.007 Hemphill, 1995, Immunology and morphology studies on the proliferation of in vitro cultivated Echinococcus multilocularis metacestodes, Parasitol. Res., 81, 605, 10.1007/BF00932028 Hemphill, 2006, Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections, Expert. Opin. Pharmacother., 7, 953, 10.1517/14656566.7.7.953 Hemphill, 2010, Echinococcus metacestodes as laboratory models for the screening of drugs against cestodes and trematodes, Parasitology, 137, 569, 10.1017/S003118200999117X Hemphill, 2014, Treatment of echinococcosis: albendazole and mebendazole - what else?, Parasite Paris Fr., 21, 70, 10.1051/parasite/2014073 Horton, 1989, Chemotherapy of Echinococcus infection in man with albendazole, Trans. R. Soc. Trop. Med. Hyg., 83, 97, 10.1016/0035-9203(89)90724-4 Horton, 1997, Albendazole in treatment of human cystic echinococcosis: 12 years of experience, Acta Trop., 64, 79, 10.1016/S0001-706X(96)00640-7 Huang, 2018, The effects of taxanes, vorinostat and doxorubicin on growth and proliferation of Echinococcus multilocularis metacestodes assessed with magnetic resonance imaging and simultaneous positron emission tomography, Oncotarget, 9, 9073, 10.18632/oncotarget.24142 Hübner, 2010, Effects of in vitro exposure of Echinococcus multilocularis metacestodes to cytostatic drugs on in vivo growth and proliferation of the parasite, Parasitol. Res., 107, 459, 10.1007/s00436-010-1892-0 Inaoka, 1987, Experimental therapy in Chinese hamsters and rats infected with larval Echinococcus multilocularis by using mebendazole, albendazole and ivermectin with brief review of chemotherapy of human multilocular echinococcosis, Hokkaido Igaky Zasshi, 62, 54 Ingold, 1999, Efficacies of albendazole sulfoxide and albendazole sulfone against in vitro-cultivated Echinococcus multilocularis metacestodes, Antimicrob. Agents Chemother., 43, 1052, 10.1128/AAC.43.5.1052 Joekel, 2018, Evaluation of kinase-inhibitors nilotinib and everolimus against alveolar echinococcosis in vitro and in a mouse model, Exp. Parasitol., 188, 65, 10.1016/j.exppara.2018.04.002 Jura, 1996, Hepatic tissue culture model for study of host-parasite interactions in alveolar echinococcosis, Infect. Immun., 64, 3484, 10.1128/IAI.64.9.3484-3490.1996 Keiser, 2009, Mefloquine—an aminoalcohol with promising antischistosomal properties in mice, PLoS Negl. Trop. Dis., 3, 10.1371/journal.pntd.0000350 Keiser, 2009, Dose-response relationships and tegumental surface alterations in Opisthorchis viverrini following treatment with mefloquine in vivo and in vitro, Parasitol. Res., 105, 261, 10.1007/s00436-009-1395-z Kern, 2008, Critical appraisal of nitazoxanide for the treatment of alveolar echinococcosis, Am. J. Trop. Med. Hyg., 79, 119 Kern, 2017, The echinococcoses, diagnosis, clinical management and burden of disease. Adv. Parasitol., 96, 259 Koziol, 2015, Recent advances in Echinococcus genomics and stem cell research, Vet. Parasitol., 213, 92, 10.1016/j.vetpar.2015.07.031 Koziol, 2013, Anatomy and development of the larval nervous system in Echinococcus multilocularis, Front. Zool., 10, 24, 10.1186/1742-9994-10-24 Koziol, 2014, The unique stem cell system of the immortal larva of the human parasite Echinococcus multilocularis, EvoDevo, 5, 10, 10.1186/2041-9139-5-10 Küster, 2011, In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis, Antimicrob. Agents Chemother., 55, 713, 10.1128/AAC.01392-10 Küster, 2012, A new promising application for highly cytotoxic metal compounds: η6-areneruthenium(II) phosphite complexes for the treatment of alveolar echinococcosis, J. Med. Chem., 55, 4178, 10.1021/jm300291a Küster, 2012, Voluntary ingestion of antiparasitic drugs emulsified in honey represents an alternative to gavage in mice, J. Am. Assoc. Lab. Anim. Sci., 51, 219 Küster, 2013, Subcutaneous infection model facilitates treatment assessment of secondary Alveolar echinococcosis in mice, PLoS Negl. Trop. Dis., 7, 10.1371/journal.pntd.0002235 Küster, 2013, In vitro and in vivo activities of dicationic diguanidino compounds against Echinococcus multilocularis metacestodes, Antimicrob. Agents Chemother., 57, 3829, 10.1128/AAC.02569-12 Küster, 2014, Amino ozonides exhibit in vitro activity against Echinococcus multilocularis metacestodes, Int. J. Antimicrob. Agents, 43, 40, 10.1016/j.ijantimicag.2013.09.012 Küster, 2014, Activities of fenbendazole in comparison with albendazole against Echinococcus multilocularis metacestodes in vitro and in a murine infection model, Int. J. Antimicrob. Agents, 43, 335, 10.1016/j.ijantimicag.2014.01.013 Küster, 2015, Oral treatments of Echinococcus multilocularis-infected mice with the antimalarial drug mefloquine that potentially interacts with parasite ferritin and cystatin, Int. J. Antimicrob. Agents, 46, 546, 10.1016/j.ijantimicag.2015.07.016 Lacey, 1990, Mode of action of benzimidazoles, Parasitol. Today Pers. Ed, 6, 112, 10.1016/0169-4758(90)90227-U Li, 2016, Comparative evaluation of liposomal albendazole and tablet-albendazole against hepatic cystic echinococcosis: a non-randomized clinical trial, Medicine (Baltimore), 95 Liance, 1993, Experience with doxorubicin-bound polyisohexylcyanoacrylate nanoparticles on murine alveolar echinococcosis of the liver, Int. J. Parasitol., 23, 427, 10.1016/0020-7519(93)90023-R Liu, 2016, Niclosamide inhibits epithelial-mesenchymal transition and tumor growth in lapatinib-resistant human epidermal growth factor receptor 2-positive breast cancer, Int. J. Biochem. Cell Biol., 71, 12, 10.1016/j.biocel.2015.11.014 Lubinsky, 1969, Attempts at chemotherapy of Echinococcus multilocularis infections in rodents, Can. J. Zool., 47, 1001, 10.1139/z69-161 Lubinsky, 1969, Gerbils as a primary screen in experimental chemotherapy of infections with larval Echinococcus multilocularis Leuck., 1863, J. Parasitol., 55, 224, 10.2307/3277378 Lubinsky, 1969, Cyclophosphamide and the survival time of mice infected with Echinococcus multilocularis cysts, Can. J. Zool., 47, 144, 10.1139/z69-027 Lubinsky, 1971, Attempts at chemotherapy of echinococcus multilocularis infections in rodents. II. A study of some parasiticides and cytostatic agents, Can. J. Zool., 49, 1301, 10.1139/z71-196 Lv, 2013, In vitro and in vivo treatments of Echinococcus granulosus with Huaier aqueous extract and albendazole liposome, Parasitol. Res., 112, 193, 10.1007/s00436-012-3125-1 Macedo, 2016, Chloroquine-containing organoruthenium complexes are fast-acting multistage antimalarial agents, Parasitology, 143, 1543, 10.1017/S0031182016001153 Mahanty, 2011, Sensitive in vitro system to assess morphological and biochemical effects of praziquantel and albendazole on Taenia solium cysts, Antimicrob. Agents Chemother., 55, 211, 10.1128/AAC.00761-10 Manneck, 2010, Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni, Parasitology, 137, 85, 10.1017/S0031182009990965 Mathis, 2005, Mitochondrial ribosome as the target for the macrolide antibiotic clarithromycin in the helminth Echinococcus multilocularis, Antimicrob. Agents Chemother., 49, 3251, 10.1128/AAC.49.8.3251-3255.2005 Matsumoto, 2008, Anaerobic NADH-fumarate reductase system is predominant in the respiratory chain of Echinococcus multilocularis, providing a novel target for the chemotherapy of alveolar echinococcosis, Antimicrob. Agents Chemother., 52, 164, 10.1128/AAC.00378-07 Mehlhorn, 1983, Proliferation and metastases formation of larval Echinococcus multilocularis, Z. Für Parasitenkd., 69, 749, 10.1007/BF00927424 Messina, 1999, Legumes and soybeans: overview of their nutritional profiles and health effects, Am. J. Clin. Nutr., 70, 439S, 10.1093/ajcn/70.3.439s Mikhaĭlitsyn, 1991, The search for new antiparasitic agents. 8. The synthesis and study of the acute toxicity, anti-alveolar hydatid and antihymenolepiasis activity of 1-alkyl-4[4-(heterylamino)phenyl]piperazines, Med. Parazitol. (Mosk.), 55 Mikhaĭlitsyn, 1994, [The search for new antiparasitic agents. 12. The synthesis and study of the anti-Echinococcus and anti-hymenolepis activity of 6-[4-(4-alkylpiperazinyl-1)-phenylamino]-1,2,5-thiadazolo[3,4-h] quinolines], Med. Parazitol. (Mosk.), 41 Miyaji, 1993, Failure of treatment with alpha-difluoromethylornithine against secondary multilocular echinococcosis in mice, Parasitol. Res., 79, 75, 10.1007/BF00931222 Mizukami, 2010, Gene silencing in Echinococcus multilocularis protoscoleces using RNA interference, Parasitol. Int., 59, 647, 10.1016/j.parint.2010.08.010 Müller, 2008, Thiazolides inhibit growth and induce glutathione-S-transferase Pi (GSTP1)-dependent cell death in human colon cancer cells, Int. J. Cancer, 123, 1797, 10.1002/ijc.23755 Müller, 2009, Thioureides of 2-(phenoxymethyl)benzoic acid 4-R substituted: a novel class of anti-parasitic compounds, Parasitol. Int., 58, 128, 10.1016/j.parint.2008.12.003 Naguleswaran, 2006, In vitro metacestodicidal activities of genistein and other isoflavones against Echinococcus multilocularis and Echinococcus granulosus, Antimicrob. Agents Chemother., 50, 3770, 10.1128/AAC.00578-06 Nikendei, 2019, Psychological burden and resilience factors in patients with alveolar Echinococcosis - a cross-sectional study, PLoS Negl. Trop. Dis., 13, 10.1371/journal.pntd.0007082 Novak, 1990, Efficacy of mitomycin C against alveolar Echinococcus, Int. J. Parasitol., 20, 119, 10.1016/0020-7519(90)90182-M Panic, 2014, Repurposing drugs for the treatment and control of helminth infections, Int. J. Parasitol. Drugs Drug Resist., 4, 185, 10.1016/j.ijpddr.2014.07.002 Pensel, 2018, Albendazole nanocrystals in experimental alveolar echinococcosis: enhanced chemoprophylactic and clinical efficacy in infected mice, Vet. Parasitol., 251, 78, 10.1016/j.vetpar.2017.12.022 Pike, 1999, Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist, EMBO J., 18, 4608, 10.1093/emboj/18.17.4608 Rausch, 1957, Studies on the helminth fauna of Alaska. XXXI. Observations on the propagation of the larval Echinococcus multilocularis Leuckart, 1863, in vitro, J. Parasitol., 43, 1, 10.2307/3274741 Rehmann, 2003, Echinococcus multilocularis in two lowland gorillas (Gorilla g. gorilla), J. Comp. Pathol., 129, 85, 10.1016/S0021-9975(02)00159-7 Reuter, 2003, Salvage treatment with amphotericin B in progressive human alveolar echinococcosis, Antimicrob. Agents Chemother., 47, 3586, 10.1128/AAC.47.11.3586-3591.2003 Reuter, 2003, Effect of amphotericin B on larval growth of Echinococcus multilocularis, Antimicrob. Agents Chemother., 47, 620, 10.1128/AAC.47.2.620-625.2003 Reuter, 2004, Structured treatment interruption in patients with alveolar echinococcosis, Hepatol. Baltim. Md, 39, 509, 10.1002/hep.20078 Reuter, 2006, In vitro activities of itraconazole, methiazole, and nitazoxanide versus Echinococcus multilocularis larvae, Antimicrob. Agents Chemother., 50, 2966, 10.1128/AAC.00476-06 Ricken, 2017, Albendazole increases the inflammatory response and the amount of Em2-positive small particles of Echinococcus multilocularis (spems) in human hepatic alveolar echinococcosis lesions, PLoS Negl. Trop. Dis., 11, 10.1371/journal.pntd.0005636 Ritler, 2017, Development of a movement-based in vitro screening assay for the identification of new anti-cestodal compounds, PLoS Negl. Trop. Dis., 11, 10.1371/journal.pntd.0005618 Rodriguez-Fonseca, 1995, Fine structure of the peptidyl transferase centre on 23 S-like rRNAs deduced from chemical probing of antibiotic-ribosome complexes, J. Mol. Biol., 247, 224, 10.1006/jmbi.1994.0135 Romig, 2017, Ecology and life cycle patterns of Echinococcus species, Adv. Parasitol., 95, 213, 10.1016/bs.apar.2016.11.002 Rufener, 2018, Repurposing of an old drug: in vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis, Int. J. Parasitol. Drugs Drug Resist., 8, 440, 10.1016/j.ijpddr.2018.10.011 Rufener, 2018, Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis, Int. J. Parasitol. Drugs Drug Resist., 8, 331, 10.1016/j.ijpddr.2018.06.004 Sander, 1997, The role of ribosomal RNAs in macrolide resistance, Mol. Microbiol., 26, 469, 10.1046/j.1365-2958.1997.5811946.x Sarciron, 1991, Treatment of experimental alveolar echinococcosis: comparative study of mebendazole, isoprinosine and a mebendazole isoprinosine association, Trop. Med. Parasitol., 42, 417 Sarciron, 1992, Effects of multiple doses of isoprinosine on Echinococcus multilocularis metacestodes, Antimicrob. Agents Chemother., 36, 191, 10.1128/AAC.36.1.191 Sarciron, 1995, Effects of Isoprinosine on Echinococcus multilocularis and E. granulosus metacestodes, Parasitol. Res., 81, 329, 10.1007/BF00931540 Schmidberger, 2018, Health-related quality of life in patients with alveolar echinococcosis: a cross-sectional study, Infection Schubert, 2014, Targeting Echinococcus multilocularis stem cells by inhibition of the Polo-like kinase EmPlk1, PLoS Negl. Trop. Dis., 8, 10.1371/journal.pntd.0002870 Siles-Lucas, 2002, Cestode parasites: application of in vivo and in vitro models for studies on the host-parasite relationship, Adv. Parasitol., 51, 133, 10.1016/S0065-308X(02)51005-8 Siles-Lucas, 2017, Laboratory diagnosis of Echinococcus spp. in human patients and infected animals, Adv. Parasitol., 96, 159, 10.1016/bs.apar.2016.09.003 Siles-Lucas, 2018, Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: compounds and therapeutic targets, PLoS Negl. Trop. Dis., 12, 10.1371/journal.pntd.0006422 Southam, 2017, The microbiology of ruthenium complexes, Adv. Microb. Physiol., 71, 1, 10.1016/bs.ampbs.2017.03.001 Spicher, 2008, In vitro and in vivo effects of 2-methoxyestradiol, either alone or combined with albendazole, against Echinococcus metacestodes, Exp. Parasitol., 119, 475, 10.1016/j.exppara.2008.02.012 Spicher, 2008, In vitro and in vivo treatments of echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives, Antimicrob. Agents Chemother., 52, 3447, 10.1128/AAC.00553-08 Spiliotis, 2004, Long-term in vitro cultivation of Echinococcus multilocularis metacestodes under axenic conditions, Parasitol. Res., 92, 430, 10.1007/s00436-003-1046-8 Spiliotis, 2008, Transient transfection of Echinococcus multilocularis primary cells and complete in vitro regeneration of metacestode vesicles, Int. J. Parasitol., 38, 1025, 10.1016/j.ijpara.2007.11.002 Spiliotis, 2010, Echinococcus multilocularis primary cells: improved isolation, small-scale cultivation and RNA interference, Mol. Biochem. Parasitol., 174, 83, 10.1016/j.molbiopara.2010.07.001 Stadelmann, 2010, Application of an in vitro drug screening assay based on the release of phosphoglucose isomerase to determine the structure-activity relationship of thiazolides against Echinococcus multilocularis metacestodes, J. Antimicrob. Chemother., 65, 512, 10.1093/jac/dkp490 Stadelmann, 2011, In vitro efficacy of dicationic compounds and mefloquine enantiomers against Echinococcus multilocularis metacestodes, Antimicrob. Agents Chemother., 55, 4866, 10.1128/AAC.00478-11 Stadelmann, 2014, Profound activity of the anti-cancer drug bortezomib against Echinococcus multilocularis metacestodes identifies the proteasome as a novel drug target for cestodes, PLoS Negl. Trop. Dis., 8, 10.1371/journal.pntd.0003352 Stadelmann, 2016, Screening of the open source malaria box reveals an early Lead compound for the treatment of alveolar echinococcosis, PLoS Negl. Trop. Dis., 10, 10.1371/journal.pntd.0004535 Stettler, 2003, In vitro parasiticidal effect of Nitazoxanide against Echinococcus multilocularis metacestodes, Antimicrob. Agents Chemother., 47, 467, 10.1128/AAC.47.2.467-474.2003 Stettler, 2004, Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activity, Int. J. Parasitol., 34, 615, 10.1016/j.ijpara.2004.01.006 Stumpe, 2007, F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy, Infection, 35, 11, 10.1007/s15010-007-6133-9 Tanowitz, 1993, Diagnosis and treatment of intestinal helminths. I. Common intestinal cestodes, Gastroenterologist, 1, 265 Tappe, 2009, Limitations of amphotericin B and nitazoxanide in the treatment of alveolar echinococcosis, Ann. Trop. Med. Parasitol., 103, 177, 10.1179/136485909X385036 Tickell-Painter, 2017, Mefloquine for preventing malaria during travel to endemic areas, Cochrane Database Syst. Rev., 10 Torgerson, 2008, Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years, J. Hepatol., 49, 72, 10.1016/j.jhep.2008.03.023 Trotz-Williams, 2017, Public health follow-up of suspected exposure to Echinococcus multilocularis in southwestern Ontario, Zoonoses Public Health, 64, 460, 10.1111/zph.12326 Tsai, 2013, The genomes of four tapeworm species reveal adaptations to parasitism, Nature, 496, 57, 10.1038/nature12031 Walter, 1987, Filaricidal effect of mefloquine on adults and microfilariae of Brugia patei and Brugia malayi, Trop. Med. Parasitol., 38, 55 Wang, 2015, Deletion of fibrinogen-like protein 2 (FGL-2), a novel CD4+ CD25+ Treg effector molecule, leads to improved control of Echinococcus multilocularis infection in mice, PLoS Negl. Trop. Dis., 9, 10.1371/journal.pntd.0003755 Wang, 2017, Depletion of FoxP3(+) Tregs improves control of larval Echinococcus multilocularis infection by promoting co-stimulation and Th1/17 immunity, Immun. Inflammation Dis., 10.1002/iid3.181 Wang, 2018, Foxp3+ T regulatory cells as a potential target for immunotherapy against primary infection with Echinococcus multilocularis eggs, Infect. Immun., 86, 10.1128/IAI.00542-18 Wang, 2018, Immunotherapy of alveolar echinococcosis via PD-1/PD-L1 immune checkpoint blockade in mice, Parasite Immunol., 40, 10.1111/pim.12596 Xiao, 1995, Effect of antihydatid drugs on carbohydrate metabolism of metacestode of echinococcus granulosus, Chin. Med. J., 108, 682 Yuan, 2016, Efficacy of osthole for Echinococcus granulosus in vitro and Echinococcus multilocularis in vivo, Vet. Parasitol., 226, 38, 10.1016/j.vetpar.2016.05.016